Viral Vector & Plasmid DNA Manufacturing Market Worth $882.9 Million By 2025: Grand View Research, Inc.

Viral Vector & Plasmid DNA Manufacturing Market Worth $882.9 Million By 2025: Grand View Research, Inc.

PR Newswire

SAN FRANCISCO, January 23, 2019

SAN FRANCISCO, January 23, 2019 /PRNewswire/ --

The global viral vector & plasmid DNA manufacturing market size is expected to reach USD 882.9 million by 2025, according to a new report by Grand View Research, Inc., rising at a 16.0% CAGR during the forecast period. Rising number of gene therapy-based discovery programs in the pharma industry is one of the key trends driving the production of gene therapy vectors. Moreover, a robust pipeline of viral vaccines and gene therapies has prompted companies to develop novel and effective technologies for scalable manufacturing of vectors. Current vector manufacturing process is considered highly regulated, elaborate, and expensive.

     (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Key suggestions from the report:  

Read 170 page research report with TOC on "Viral Vector & Plasmid DNA Manufacturing Market Analysis Report By Application, By Disease (Cancer, Genetic), By Workflow (Upstream, Downstream), By Vector, By End Use, And Segment Forecasts, 2019 - 2025" at:  https://www.grandviewresearch.com/industry-analysis/viral-vector-manufacturing-market

Moreover, at present, there is a shortage of production sites to meet the demand by the pharmaceutical industry for vector construction services. These factors have created opportunities for companies to capitalize on potential avenues in the market through developing novel solutions.

Key growth strategies adopted by companies to sustain their market presence include continuous expansion of manufacturing sites in high-demand markets such as the U.S. and U.K. Moreover, companies are engaged in strategic mergers & facility acquisitions to meet growing requirements of viral vectors within the pharmaceutical and biotech industries and to broaden their service portfolios.

Connect with our analyst for specific inquiries about this market

Grand View Research has segmented the global viral vector & plasmid DNA manufacturing market on the basis of vector type, workflow, application, end-use, disease, and region: 

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

Browse related reports by Grand View Research: 

About Grand View Research 

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter


Voltar noticias em Inglês